tiprankstipranks
Hofseth Biocare ASA (HOFBF)
OTHER OTC:HOFBF

Hofseth Biocare ASA (HOFBF) Stock Price & Analysis

3 Followers

HOFBF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.18 - $0.33
Previous Close$0.18
Volume67.50K
Average Volume (3M)67.50K
Market Cap
$74.83M
Enterprise Value$81.73M
Total Cash (Recent Filing)kr29.88M
Total Debt (Recent Filing)kr104.17M
Price to Earnings (P/E)-7.7
Beta0.54
Aug 30, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding395,075,736
10 Day Avg. Volume0
30 Day Avg. Volume67,500
Standard Deviation0.30
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%<0.01%99.99%
0.00%
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors

HOFBF FAQ

What was Hofseth Biocare ASA’s price range in the past 12 months?
Hofseth Biocare ASA lowest stock price was $0.18 and its highest was $0.33 in the past 12 months.
    What is Hofseth Biocare ASA’s market cap?
    Currently, no data Available
    When is Hofseth Biocare ASA’s upcoming earnings report date?
    Hofseth Biocare ASA’s upcoming earnings report date is Aug 30, 2024 which is in 100 days.
      How were Hofseth Biocare ASA’s earnings last quarter?
      Hofseth Biocare ASA released its earnings results on May 16, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
        Is Hofseth Biocare ASA overvalued?
        According to Wall Street analysts Hofseth Biocare ASA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Hofseth Biocare ASA pay dividends?
          Hofseth Biocare ASA does not currently pay dividends.
          What is Hofseth Biocare ASA’s EPS estimate?
          Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Hofseth Biocare ASA have?
          Hofseth Biocare ASA has 395,081,020 shares outstanding.
            What happened to Hofseth Biocare ASA’s price movement after its last earnings report?
            Hofseth Biocare ASA reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Hofseth Biocare ASA?
              Currently, no hedge funds are holding shares in HOFBF
              ---

              Hofseth Biocare ASA Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -46.66%
              12-Months-Change

              Fundamentals

              Return on Equity
              -72.72%
              Trailing 12-Months
              Asset Growth
              -3.60%
              Trailing 12-Months

              Company Description

              Hofseth Biocare ASA

              Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium and nonwater soluble protein. The brands under the company are OmeGo, ProGo, and CalGo. The firm sells the products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cansortium
              Vericel
              Green Thumb Industries
              Cronos Group
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis